These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 6129059)

  • 41. [Improved protection of the myocardium with a combination of intra-aortic balloon counter-pulsation and aimed substrate administration in acute myocardial infarct--a comparative study].
    Lindenau KF; Goos H; David H; Krause EG; Jonas B; Liebetruth J; Schubel B; Nöhring J; Warnke H
    Z Exp Chir; 1982 Feb; 15(1):24-37. PubMed ID: 7043924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myofibrillar alterations in ischemic myocardium after glucose-insulin-potassium infusion.
    Sybers HD; Ashraf M
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():415-21. PubMed ID: 1197893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of "polarizing" solutions (glucose, potassium, insulin) in acute coronary insufficiency. Review of the literature and the authors' data].
    Chernov AZ; Gerchikova TN
    Ter Arkh; 1969 Nov; 41(11):8-13. PubMed ID: 4916348
    [No Abstract]   [Full Text] [Related]  

  • 44. Decision making in the routine management of myocardial infarction.
    Deshmukh H; Weil MH; Rackow EC
    Acute Care; 1986; 12(2):95-107. PubMed ID: 2899371
    [No Abstract]   [Full Text] [Related]  

  • 45. Beneficial effect of combined glucose-insulin-potassium and mechanical support in acute myocardial ischaemia.
    Pissarek M; Goos H; Nöhring J; Kensicki C; Jonas B; Liebetruth J; Lindenau KF; Krause EG
    Biomed Biochim Acta; 1986; 45(5):629-36. PubMed ID: 3530251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocardial salvage: pharmacologic treatment.
    Sanders AB
    Emerg Med Clin North Am; 1988 May; 6(2):361-72. PubMed ID: 2894982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Advances in coronary surgery: acute myocardial infarct and revascularization surgery].
    Concha Ruiz M
    Rev Esp Cardiol; 1984; 37 Suppl 1():16-25. PubMed ID: 6390586
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pathogenetic mechanisms of the spread of the lesion focus in myocardial infarct and measures for its limitation (a review of the literature)].
    Gritsiuk AI
    Vrach Delo; 1987 Sep; (9):1-7. PubMed ID: 2892315
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of Acute MI. Institute for Clinical Systems Improvement.
    Postgrad Med; 1999 Nov; 106(6):57-8, 62-4, 74-6; passim. PubMed ID: 10576003
    [No Abstract]   [Full Text] [Related]  

  • 51. [The development of ischemic damage to the myocardium and a review of methods which decrease it].
    Slezák J
    Bratisl Lek Listy; 1986 Mar; 85(3):345-62. PubMed ID: 3513913
    [No Abstract]   [Full Text] [Related]  

  • 52. Myocardial ischemia (second of three parts).
    Hillis LD; Braunwald E
    N Engl J Med; 1977 May; 296(18):1034-41. PubMed ID: 321964
    [No Abstract]   [Full Text] [Related]  

  • 53. Recognition and management of myocardial ischemia.
    Prida X; Pepine CJ
    Compr Ther; 1987 Apr; 13(4):6-11. PubMed ID: 2882886
    [No Abstract]   [Full Text] [Related]  

  • 54. [Principles, means and potentials for decreasing hospital mortality in acute myocardial infarct].
    Petrov K
    Vutr Boles; 1985; 24(2):36-43. PubMed ID: 3898585
    [No Abstract]   [Full Text] [Related]  

  • 55. [Current trends in the treatment of acute myocardial infarct].
    Georgescu G
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(1):19-28. PubMed ID: 6443724
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effectiveness of combined therapy (systemic thrombolysis, I.V. nitroglycerin and acute beta blockade) in acute myocardial ischemia].
    Szelier A; Szabó P; Turi T; Simon K
    Orv Hetil; 1987 May; 128(22):1149-55. PubMed ID: 2886964
    [No Abstract]   [Full Text] [Related]  

  • 57. Myocardial infarction--coronary care.
    Holmberg S
    Acta Med Scand Suppl; 1986; 712():29-34. PubMed ID: 2880461
    [No Abstract]   [Full Text] [Related]  

  • 58. Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase.
    Opie LH
    Am Heart J; 1980 Oct; 100(4):531-52. PubMed ID: 6106384
    [No Abstract]   [Full Text] [Related]  

  • 59. [Physio-pharmacology of coronary insufficiency. I].
    Campese VM; Marino A
    Clin Ter; 1974 Mar; 69(4):301-20. PubMed ID: 4152441
    [No Abstract]   [Full Text] [Related]  

  • 60. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction: safety and biochemical effects.
    Simon K; Szépvölgyi A
    Circulation; 1996 Oct; 94(7):1791. PubMed ID: 8840884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.